- Visibility 298 Views
- Downloads 314 Downloads
- Permissions
- DOI 10.18231/j.ijmmtd.v.11.i.3.11
-
CrossMark
Characterization of bacterial pathogens in Diabetic skin and soft tissue infections: A hospital-based study in Sohar, Oman
- Author Details:
-
Sendhil Coumary Arumugam
-
Rokia Abdullah Sulaiman Al Zakwani
-
Reem Aamir Hadoob Aamir Al Malki
-
Noor Badar Abdullah Al Nadabi
-
Al Hanuf Ali Saif Ali Al Abri
Sendhil Coumary Arumugam
Introduction: Diabetes mellitus (DM) is a commonly prevalent, long-term metabolic condition that contributes to damage in multiple organs, resulting in significant health issues and financial burdens. In Oman, the prevalence of diabetes stands at 15.7%. Over the past 20 years, the emergence of multidrug-resistant (MDR) organisms has become a major global concern, complicating the management of diabetic foot infections (DFIs) and often leading to treatment failure, morbidity, and mortality.
Materials and Methods: This retrospective study reviewed medical records of diabetic patients with skin and soft tissue infections (SSTIs) who were hospitalized at New Sohar Hospital from January 2020 to December 2022. Data collected included patient demographics, diabetes-related details, microbiology samples, and lab findings. Pathogens were identified through Gram staining and culture.
Results: A total of 200 samples were collected from 71 patients, with 197 showing positive bacterial cultures. The average age of the patients was 60.06 ± 17.25 years. Diabetic foot ulcers were the most frequently observed type of infection. Gram-negative bacteria (73.6%) were more prevalent than Gram-positive bacteria (26.4%). The most commonly isolated Gram-negative bacterium was Proteus mirabilis (17.3%), while Staphylococcus aureus (10.1%) was the leading Gram-positive isolate. Older age was associated with a higher incidence of MDR organisms. Poor glycaemic control was significantly linked to MDR infections, with a p-value of 0.048.
Conclusion: The findings highlight that diabetic foot ulcers are the most prevalent SSTIs among diabetic patients. Gram-negative bacteria were the dominant pathogens, showing good susceptibility to beta-lactam antibiotics but resistance to third-generation cephalosporins. In contrast, trimethoprim-sulfamethoxazole and gentamicin were more effective against Gram-positive organisms. These insights are valuable for guiding empirical antibiotic choices in diabetic patients with SSTIs, particularly foot ulcers. Ongoing surveillance of bacterial strains and their resistance profiles is crucial for improving treatment strategies, reducing healthcare costs, and preventing the development of resistant bacteria.
References
- Goyal R, Singhal M, Jialal I. Type 2 Diabetes. [Updated 2023 Jun 23]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan . Available from: https://www.ncbi.nlm.nih.gov/books/NBK513253/
- Wou C, Unwin N, Huang Y, Roglic G. Implications of the growing burden of diabetes for premature cardiovascular disease mortality and the attainment of the Sustainable Development Goal target 3.4. Cardiovasc Diagn Ther. 2019;9(2):140–9.
- Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402(10397):203–34.
- Ministry of Health. Annual health report 2020. [Cited 2022 May 31]. Available from: https://www.moh.gov.om/en/web/statistics/-/-2020.
- IDF diabetes atlas. 10th edition 2021. https://www.ncbi.nlm.nih.gov/books/NBK581934/
- Awad SF, Al-Mawali A, Al-Lawati JA, Morsi M, Critchley JA, Abu-Raddad LJ. Forecasting the type 2 diabetes mellitus epidemic and the role of key risk factors in Oman up to 2050: Mathematical modeling analyses. J Diabetes Investig. 2021;12(7):1162–74.
- Suaya JA, Eisenberg DF, Fang C, Miller LG. Skin and Soft Tissue Infections and Associated Complications among Commercially Insured Patients Aged 0–64 Years with and without Diabetes in the U.S. PLoS ONE. 2013;8(4):e60057.
- Afroz Z, Metri BC, Jyothi, P. Bacteriological profile and antimicrobial susceptibility pattern of skin and soft tissue infections among gram negative bacilli in a tertiary care hospital of south India. J Pharm Sci Res. 2015;7(7):397–400.
- Mohanty DP, Mulki SS, Mishra DN. Clinico-Microbiological Profile of Diabetic Foot Ulcer: The common Anatomical site. J Med Sci Clin Res. 2017;5(8):26585–93.
- Mendes JJ, Marques-Costa A, Vilela C, Neves J, Candeias N, Cavaco-Silva P, et al. Clinical and bacteriological survey of diabetic foot infections in Lisbon. Diabetes Res Clin Pract. 2012;95(1):153–
- Sannathimmappa MB, Nambiar V, Aravindakshan R, Al Khabori MSJ, Al-Flaiti AHS, Al-Azri KNM, et al. Diabetic foot infections: Profile and antibiotic susceptibility patterns of bacterial isolates in a tertiary care hospital of Oman. J Educ Health Promot. 2021;10:254.
- Muteeb G, Rehman MT, Shahwan M, Aatif M. Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review. Pharmaceuticals (Basel). 2023;16(11):1615.
- Ki V, Rotstein C. Bacterial skin and soft tissue infections in adults: A review of their epidemiology, pathogenesis, diagnosis, treatment and site of care. Can J Infect Dis Med Microbiol. 2008;19(2):173–
- Kim J. The pathophysiology of diabetic foot: a narrative review. J Yeungnam Med Sci. 2023;40(4):328–34.
- Monk EJM, Jones TPW, Bongomin F, Kibone W, Nsubuga Y, Ssewante N, et al. Antimicrobial resistance in bacterial wound, skin, soft tissue and surgical site infections in Central, Eastern, Southern and Western Africa: A systematic review and meta-analysis. PLOS Glob Public Health. 2024;4(4):e0003077.
- Mustăţea P, Bugă C, Doran H, Mihalache O, Bobîrcă FT, Georgescu DE, et al. Soft Tissue Infections in Diabetic Patients. Chirurgia (Bucur). 2018;113(5):651–67.
- Anwer A, Ghummon AK, Rana MSM, Rasheed S, Hamid F, Gul J. Prevalence of Skin and Soft Tissue Infections in Diabetic Patients in a District Headquarters Hospital of, Pakistan. Pak J Med Health Sci. 2022;16(09):878.
- Long AN, Dagogo-Jack S. Comorbidities of diabetes and hypertension: mechanisms and approach to target organ protection. J Clin Hypertens (Greenwich). 2011;13(4):244–51.
- Alshaya A, Alsayegh A, Alshaya H, Almutlaq B, Alenazi N, Rasheedi H, et al. The Common Complications and Comorbidities among Saudi Diabetic Patients in Northern Saudi Arabia. Open J Endocr Metab Dis. 2017;7:151–61.
- Asumanu E, Ametepi R, Koney CT. Audit of diabetic soft tissue infection and foot disease in Accra. West Afr J Med. 2010;29(2):86-
- Sekhar S, Vyas N, Unnikrishnan M, Rodrigues G, Mukhopadhyay C. Antimicrobial susceptibility pattern in diabetic foot ulcer: a pilot study. Ann Med Health Sci Res. 2014;4(5):742–5.
- Hitam SAS, Hassan SA, Maning N. The Significant Association between Polymicrobial Diabetic Foot Infection and Its Severity and Outcomes. Malays J Med Sci. 2019;26(1):107–14.
- Ramakant P, Verma AK, Misra R, Prasad KN, Chand G, Mishra A, et al. Changing microbiological profile of pathogenic bacteria in diabetic foot infections: time for a rethink on which empirical therapy to choose? Diabetologia. 2011;54(1):58-64.
- Lipsky BA, Tabak YP, Johannes RS, Vo L, Hyde L, Weigelt JA. Skin and soft tissue infections in hospitalised patients with diabetes: culture isolates and risk factors associated with mortality, length of stay and cost. Diabetologia. 2010;53(5):914–23.
- Dunyach-Remy C, Ngba Essebe C, Sotto A, Lavigne JP. Staphylococcus aureus Toxins and Diabetic Foot Ulcers: Role in Pathogenesis and Interest in Diagnosis. Toxins (Basel). 2016;8(7):209.
- Mutonga DM, Mureithi MW, Ngugi NN, Otieno FCF. Bacterial isolation and antibiotic susceptibility from diabetic foot ulcers in Kenya using microbiological tests and comparison with RT-PCR in detection of S. aureus and MRSA. BMC Res Notes. 2019;12(1):244.
- Alfouzan W, Al-Balushi Z, Al-Maslamani M, Al-Rashed A, Jameela S, Baguneid M, et al. Antimicrobial Management of Complicated Skin and Soft Tissue Infections in an Era of Emerging Multi-Drug Resistance: Perspectives from 5 Gulf Countries. J Acute Care Surg. 2021;11(3):89–101.
- Yan X, Song JF, Zhang L, Li X. Analysis of risk factors for multidrug-resistant organisms in diabetic foot infection. BMC Endocr Disord. 2022;22(1):46.
- Kathirvel M, Prabakaran V, Jayarajan J, Sivakumar A, Govindan V. Risk factors for the diabetic foot infection with multidrug-resistant microorganisms in South India. Int Surg J. 2018;5(2):675–82.
- Benavent E, Murillo O, Grau I, Laporte-Amargos J, Gomez-Junyent J, Soldevila L, et al. The Impact of Gram-Negative Bacilli in Bacteremic Skin and Soft Tissue Infections Among Patients With Diabetes. Diabetes Care. 2019;42(7):e110–2.